Translational Development Acquisition Corp.

NASDAQ:TDAC

Shell Companies

Financial Services
$10.88 -0.09%

-$0.01 today

Market cap
$267.99M
Beta
0.01
P/E (TTM)
29.8
EPS (TTM)
$0.36
52W Low $10.27High $10.80

Volume 0.47M

Average 0.10M

TDAC Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Translational Development Acquisition Corp.NASDAQ: TDAC

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables remains negative

Q1 FY2026 net receivables was $0, compared with $0 a year earlier.

Context

  • Net receivables amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Net receivables increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Net Receivables vs competitors

How TDAC compares with its peers on the latest reported figures

  • TDAC's Mar 2026 net receivables of $0 is the 4th highest of the 7 companies compared; the peer median is $8.35K.
  • Net receivables amounts to 0.0% of total assets for TDAC, versus a peer median of 0.0%.
TDAC Competitors Peer median
Net Receivables for TDAC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MACIMelar Acquisition Corp. IMar 2026$3.96M ——2.2%
NTWONewbury Street II Acquisition CorpMar 2026$38.17K +52.7%—0.0%
SZZLSizzle Acquisition Corp. IIMar 2026$16.69K ——0.0%
TDACTranslational Development Acquisition Corp.Mar 2026$0 ——0.0%
FACTFACT II Acquisition CorpMar 2026$0 ——0.0%
CEPOCantor Equity Partners I, Inc. Class A Ordinary SharesMar 2026$0 ——0.0%
HCMAHCM Acquisition CorpJun 2025$0 ——0.0%
Peer median (excluding TDAC) $8.35K+52.7%—0.0%

Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.23K2.02K438.17K29.79K
Short-term Investments0000
Net Receivables0000
Inventory0000
Other Current Assets0000
Total Current Assets54.23K2.02K650.23K39.47K
Property, Plant & Equipment (Net)0000
Goodwill009.06T0
Intangible Assets0012.57T0
Long-term Investments00174.35M181.66M
Tax Assets0000
Other Non-current Assets383.01K0(21.63T)0
Total Non-current Assets383.01K0174.35M181.66M
Total Assets437.24K2.02K175M181.7M
Account Payables01.25K16.19K162.31K
Short-term Debt259K347.5K6.11T200K
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities200.34K(1.25K)(6.11T)0
Total Current Liabilities459.39K509.68K210.3K544.07K
Long-term Debt0000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities006.04M6.04M
Total Non-current Liabilities(50)06.04M6.04M
Total Liabilities459.34K509.68K6.25M6.58M
Common Stock46646618.33B181.66M
Retained Earnings(47.11K)(532.66K)(5.6M)(6.54M)
Accumulated OCI0016.88B0
Other Stockholders Equity00(35.03B)0
Minority Interest0000
Total Equity(22.11K)(507.66K)168.75M175.12M
Total Debt259K347.5K6.11T200K
Net Debt256.78K345.48K(438.17K)170.21K

Translational Development Acquisition Corp.

NASDAQ:TDAC

Intrinsic Alpha fair value

Locked

Current Price

$10.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.